An in vitro cachexia model using liver cancer cells and a C26 colon cancer study demonstrated that Calpain-1 was highly upregulated in these cells, which was opposite to the calpastatin level, and the Ca2 + -dependent proteolytic pathway was highly activated in the C26 cachexia rat model [121]. The gene discussed is CAPN1; the disease is Cachexia.